Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Relmada Therapeutics, Inc.

Clinical trials sponsored by Relmada Therapeutics, Inc., explained in plain language.

Relmada Therapeutics, Inc. RLMD NASDAQ

Clinical-stage biopharmaceutical company developing therapies for central nervous system disorders.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 3

New bladder cancer drug could spare patients from bladder removal

Disease control Not yet recruiting

This Phase 3 trial tests NDV-01, a sustained-release combination of two chemotherapy drugs (gemcitabine and docetaxel), given directly into the bladder. It aims to prevent cancer from coming back in people with non-muscle invasive bladder cancer, including those who have not resp…

Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC